See more : Archana Software Limited (SSLFINANCE.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Kolon Life Science Inc. (102940.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kolon Life Science Inc., a leading company in the industry within the sector.
You may be interested
- Tai Roun Products Co.,Ltd. (1220.TW) Income Statement Analysis – Financial Results
- Surya Roshni Limited (SURYAROSNI.NS) Income Statement Analysis – Financial Results
- NCS&A Co., Ltd. (9709.T) Income Statement Analysis – Financial Results
- Kyto Technology and Life Science, Inc. (KBPH) Income Statement Analysis – Financial Results
- GPI S.p.A. (GPI.MI) Income Statement Analysis – Financial Results
Kolon Life Science Inc. (102940.KQ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 124.64B | 161.58B | 165.49B | 129.41B | 148.54B |
| Cost of Revenue | 112.23B | 124.45B | 128.28B | 110.52B | 123.18B |
| Gross Profit | 12.41B | 37.14B | 37.20B | 18.90B | 25.36B |
| Gross Profit Ratio | 9.96% | 22.98% | 22.48% | 14.60% | 17.07% |
| Research & Development | 14.89B | 13.58B | 14.33B | 13.15B | 18.49B |
| General & Administrative | 8.31B | 8.46B | 6.85B | 13.36B | 10.01B |
| Selling & Marketing | 3.15B | 3.30B | 3.75B | 4.27B | 4.76B |
| SG&A | 11.46B | 11.76B | 10.61B | 17.63B | 30.45B |
| Other Expenses | 10.15B | 8.09B | 2.01B | 2.51B | 0.00 |
| Operating Expenses | 36.51B | 26.90B | 28.98B | 58.33B | 102.28B |
| Cost & Expenses | 148.73B | 151.35B | 157.26B | 168.85B | 225.46B |
| Interest Income | 168.59M | 114.07M | 120.40M | 135.40M | 460.20M |
| Interest Expense | 5.86B | 3.72B | 6.01B | 5.52B | 3.74B |
| Depreciation & Amortization | 8.83B | 9.47B | 11.30B | 13.03B | 14.04B |
| EBITDA | -18.91B | 12.11B | 15.55B | -24.65B | -12.50B |
| EBITDA Ratio | -15.17% | 12.48% | 10.60% | -21.28% | -8.42% |
| Operating Income | -24.10B | 2.64B | 3.87B | -25.84B | -26.54B |
| Operating Income Ratio | -19.33% | 1.63% | 2.34% | -19.96% | -17.87% |
| Total Other Income/Expenses | -9.50B | 1.48B | -7.88B | -17.36B | -53.65B |
| Income Before Tax | -33.60B | 4.12B | -4.01B | -43.20B | -80.20B |
| Income Before Tax Ratio | -26.96% | 2.55% | -2.42% | -33.38% | -53.99% |
| Income Tax Expense | 1.25M | 107.93M | -2.64B | -14.74B | 12.13B |
| Net Income | -30.73B | 2.13B | -1.37B | -43.20B | -92.32B |
| Net Income Ratio | -24.65% | 1.32% | -0.83% | -33.38% | -62.15% |
| EPS | -2.69K | 187.00 | -121.00 | -3.79K | -8.10K |
| EPS Diluted | -2.43K | 163.00 | -121.00 | -3.79K | -8.10K |
| Weighted Avg Shares Out | 11.41M | 11.41M | 11.36M | 11.40M | 11.40M |
| Weighted Avg Shares Out (Dil) | 12.64M | 13.09M | 11.36M | 11.40M | 11.40M |
No news found for: 102940.KQ
Source: https://incomestatements.info
Category: Stock Reports